Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx

Head and Neck

Volumn 33, Issue 1, 2011, Pages 103-111

  Daly, Megan E ^a   Le, Quynh Thu ^a   Jain, Anshu K ^a   Maxim, Peter G ^a   Hsu, Annie ^a   Loo Jr , Billy W ^a   Kaplan, Michael J ^a   Fischbein, Nancy J ^b   Colevas, A Dimitrios ^a   Pinto, Harlan ^a,c   Chang, Daniel T ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

hypopharynx; IMRT; intensity modulated; larynx; radiotherapy; squamous cell carcinoma

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; NARCOTIC AGENT; PACLITAXEL;

ADOLESCENT; ADULT; AGED; ANALGESIA; ANAPHYLAXIS; ARTICLE; BONE NECROSIS; BONE RESECTION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; ESOPHAGUS STENOSIS; FAILURE TO THRIVE; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CARCINOMA; INTENSITY MODULATED RADIATION THERAPY; LARYNGECTOMY; LARYNX CARCINOMA; LUNG EMBOLISM; MALE; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; OVERALL SURVIVAL; PAIN; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; POOR PERFORMANCE; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION NECROSIS; SKIN MANIFESTATION; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STOMATITIS; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNGOSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78651357263     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21406     Document Type: Article

References (24)

1. Anonymous. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324: 1685-1690.
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
3. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T,. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88: 890-899.
4. Huang K, Xia P, Chuang C, et al. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer 2008; 113: 497-507.
5. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM,. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003; 57: 49-60.
6. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002; 53: 12-22.
7. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006; 64: 363-373.
8. Daly ME, Le QT, Maxim PG, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2009. doi:10.1016/j.ijrobp.2009.04.006.
9. Schoenfeld GO, Amdur RJ, Morris CG, Li JG, Hinerman RW, Mendenhall WM,. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 71: 377-385.
10. Yao M, Dornfeld KJ, Buatti JM, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma: the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005; 63: 410-421.
11. Clark CH, Bidmead AM, Mubata CD, Harrington KJ, Nutting CM,. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol 2004; 70: 189-198.
12. Lee NY, O'Meara W, Chan K, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2007; 69: 459-468.
13. Studer G, Lutolf UM, Davis JB, Glanzmann C,. IMRT in hypopharyngeal tumors. Strahlenther Onkol 2006; 182: 331-335.
14. Daly ME, Lieskovsky Y, Pawlicki T, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 2007; 29: 211-220.
15. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA,. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003; 55: 312-321.
16. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
17. Kaplan E, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
18. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001; 49: 907-916.
19. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA,. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45: 577-587.
20. Roesink JM, Moerland MA, Battermann JJ, Hordijk GJ, Terhaard CH,. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 2001; 51: 938-946.
21. van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, Lamers EA, Balm AJM, Rasch CRN,. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 2008; 3:Art. 41(10 pp).
22. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A,. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003; 57: 61-70.
23. Hall SF, Groome PA, Irish J, O'Sullivan B,. The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 2008; 118: 1362-1371.
24. Hoffman HT, Karnell LH, Shah JP, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997; 107: 1005-1017.